West Paces Advisors Inc. Merck & Co., Inc. Transaction History

West Paces Advisors Inc.

$439 Billion
Q1 2025

A detailed history of West Paces Advisors Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 21,082 shares of MRK stock, worth $1.63 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

21,082

Previous 18,881 11.66%

Holding current value

$1.63 Million

Previous $1.88 Billion 0.75%

% of portfolio

0.43%

Previous 0.46%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$83.01 - $101.02 $182,705 - $222,345	2,201 Added 11.66%	21,082 $1.89 Billion
Q4 2024 Feb 14, 2025	SELL	$96.31 - $114.76 $49,792 - $59,330	-517 Reduced 2.67%	18,881 $1.88 Billion
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $10,114 - $11,736	-91 Reduced 0.47%	19,398 $2.2 Billion
Q2 2024 Jul 16, 2024	SELL	$123.8 - $132.96 $8,418 - $9,041	-68 Reduced 0.35%	19,489 $2.41 Billion
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $85,382 - $99,490	-754 Reduced 3.71%	19,557 $2.58 Billion
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $9,216 - $10,029	-92 Reduced 0.45%	20,311 $2.21 Billion
Q3 2023 Dec 18, 2023	SELL	$102.95 - $114.33 $135,688 - $150,686	-1,318 Reduced 6.07%	20,403 $2.1 Billion
Q2 2023 Dec 18, 2023	SELL	$108.61 - $118.38 $11,512 - $12,548	-106 Reduced 0.49%	21,721 $2.51 Billion
Q1 2023 Dec 18, 2023	BUY	$102.94 - $114.86 $33,043 - $36,870	321 Added 1.49%	21,827 $2.32 Billion
Q4 2022 Dec 18, 2023	BUY	$87.44 - $112.11 $1.88 Million - $2.41 Million	21,506 New	21,506 $2.39 Billion
Q3 2022 Dec 18, 2023	BUY	$84.53 - $94.96 $1,183 - $1,329	14 Added 0.07%	21,437 $1.85 Billion
Q2 2022 Dec 18, 2023	BUY	$83.49 - $94.64 $42,830 - $48,550	513 Added 2.45%	21,423 $1.95 Billion
Q1 2022 Dec 18, 2023	BUY	$73.51 - $82.4 $37,269 - $41,776	507 Added 2.48%	20,910 $1.72 Billion
Q4 2021 Dec 19, 2023	SELL	$72.28 - $90.54 $35,200 - $44,092	-487 Reduced 2.44%	19,456 $1.49 Billion
Q3 2021 Dec 19, 2023	BUY	$71.68 - $78.83 $38,993 - $42,883	544 Added 2.8%	19,943 $1.5 Billion
Q2 2021 Dec 19, 2023	BUY	$70.31 - $77.77 $703 - $777	10 Added 0.05%	19,399 $1.51 Billion
Q1 2021 Dec 19, 2023	BUY	$68.86 - $81.11 $80,290 - $94,574	1,166 Added 6.4%	19,389 $1.49 Billion
Q4 2020 Dec 19, 2023	BUY	$71.77 - $79.65 $125,884 - $139,706	1,754 Added 10.65%	18,223 $1.49 Billion
Q3 2020 Dec 19, 2023	BUY	$73.18 - $82.95 $226,931 - $257,227	3,101 Added 23.2%	16,469 $1.37 Billion
Q2 2020 Dec 19, 2023	SELL	$70.42 - $80.13 $495,404 - $563,714	-7,035 Reduced 34.48%	13,368 $1.03 Billion
Q1 2020 Dec 20, 2023	BUY	$63.36 - $87.82 $251,032 - $347,942	3,962 Added 112.3%	7,490 $576 Million
Q4 2019 Dec 21, 2023	BUY	$77.58 - $87.54 $53,607 - $60,490	691 Added 19.59%	4,219 $384 Million
Q4 2018 Dec 21, 2023	SELL	$65.24 - $75.71 $3,457 - $4,012	-53 Reduced 1.48%	3,528 $270 Million
Q3 2018 Dec 20, 2023	SELL	$57.69 - $67.84 $973,518 - $1.14 Million	-16,875 Reduced 82.71%	3,528 $250 Million
Q2 2018 Dec 21, 2023	BUY	$50.83 - $59.72 $8,691 - $10,212	171 Added 5.01%	3,581 $217 Million
Q1 2018 Dec 21, 2023	SELL	$50.96 - $59.23 $214,490 - $249,299	-4,209 Reduced 55.24%	3,410 $186 Million
Q4 2017 Dec 21, 2023	SELL	$51.62 - $61.64 $374,245 - $446,890	-7,250 Reduced 48.76%	7,619 $429 Million
Q3 2017 Dec 21, 2023	SELL	$58.67 - $63.13 $12,438 - $13,383	-212 Reduced 1.41%	14,869 $952 Million
Q2 2017 Dec 21, 2023	SELL	N/A	-25 Reduced 0.17%	15,081 $967 Million
Q1 2017 Dec 21, 2023	BUY	N/A	569 Added 3.91%	15,106 $960 Million
Q4 2016 Dec 21, 2023	SELL	N/A	-5,866	14,537 $856 Million

Others Institutions Holding MRK

# of Institutions

3,891

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $195B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Merck & Co., Inc. Transaction History